Welcome to the 4th Bacteriophage Therapy Summit

With increasing regulatory flexibility for phage-based applications, address critical questions to help your phage technologies advance through commercial development

The Bacteriophage Therapy Summit is the definitive gathering for global phage experts. Focusing on human health and disease, the 4th Bacteriophage Therapy Summit is returning to help you advance your phage-based therapies through clinical development and commercialization beyond compassionate use.

2022 Agenda at a Glance:

500px by 500px (3)-modified

Navigate clinical trial rationale, distribution effects of formulation on reaching infection sites, lessons learned from compassionate use trials, and the regulatory pathway for commercial development with the hottest insights from our 35+ expert speaker faculty

500px by 500px (3)-modified

Hear from international organizations including the FDA, BiomX, Locus Bioscience, Felix Bioscience, Phagomed, PhagePro, Cytophage, Sciphage and unite with the phage community prioritizing human health and disease

500px by 500px (3)-modified

Discuss strategies to weaponize phage therapies including lysins, genetic engineered and combination approaches to create new pathways for the treatment of infectious diseases, across 3 days of unparalleled, industry-centered content

2022 Industry Leading Speakers Include:

Join Attendees From

Proud to Partner with

What Will You Gain?

Join 100+ International Phage Professionals:
Hear multi-disciplined perspectives from phage-developers, toxicologists, microbiologists, and investors

Share Your Own Work:
Present to thought leaders and gain critical feedback to forge partnerships and shape the trajectory of your program

Harmonize your Thoughts:
With 30+ organizations gathering to share their expectations for bacteriophage therapy, align your own thinking with the industry and identify the niche that gives you maximum return on investment

Gain Actionable Insights:
Hear how the latest scientific understanding is being applied to pipeline progress enabling you to benchmark your decisions against others in the field and acquire innovative foresight to address challenges before you encounter them

Grow Your Commercial Pipeline:
Interact with 10 focused workshop presentations, 2 days of niche content and 4 organized networking sessions

Evolve Connections:
Network one-to-one with 100 other key decision-makers across multiple perspectives prioritizing phage therapy including academics, translational and safety scientists, as well as clinical program and market access leads, and scientists developing innovative phage cocktails and modified phages